President Biden's team has unveiled several pandemic response initiatives including using the U.S. Defense Production Act (DPA), rejoining the World Health Organization, and providing more direct federal involvement in the vaccine supply chain planning. Winston & Strawn Partners Winston Kirton and Reed Stephens spoke with Biopharma Reporter on what the Biden team can do with these tools.

Read the full article here.

Visit Winston & Strawn's U.S. Election / Global Impact series for our perspectives on cross-border issues impacted by the U.S. election.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.